News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Pfizer Inc. (PFE) Expected To Unveil $2 Billion Cost-Cutting Plan



10/19/2005 5:13:11 PM

Pfizer Inc.'s stock price has tumbled by roughly a third this year amid worries about expiring patents, safety concerns about its pain reliever Celebrex and its sub-par outlook. Still, Wall Street expects few dramatic changes when the world's largest drugmaker holds a meeting for analysts and investors on Tuesday. The April 5 event in New York where the company will announce a strategic plan and earnings' projections is expected to be relatively sedate. Analysts believe the company will announce at least $2 billion in cost-cutting and a staff reduction through attrition. No epic strategy shift or executive departures are predicted, however, despite the past year's difficulties and broader industry issues, including intensifying political pressure to lower the cost of medicine.

Read at AP
Read at Dow Jones
Read at CNN Money


comments powered by Disqus
AP
Dow Jones
CNN Money
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES